Abstract
No public abstract is available from the verified source records.
Yaxing Zhang, Shiyu Xin, Kaiming Zhang, Cuixia An
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States
10.1001/jamapsychiatry.2017.4602 · 2018
The theoretical model of theta burst form of repetitive transcranial magnetic stimulation
10.1016/j.clinph.2010.08.016 · 2011
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): an update (2014-2018)
10.1016/j.clinph.2019.11.002 · 2020
Manipulating reward sensitivity using reward circuit-targeted transcranial magnetic stimulation
2022
Different synaptic mechanisms of intermittent and continuous theta-burst stimulations in a severe foot-shock induced and treatment-resistant depression in a rat model
10.1016/j.expneurol.2023.114338 · 2023
The theoretical model of theta burst form of repetitive transcranial magnetic stimulation
10.1016/j.clinph.2010.08.016 · 2011
State-Dependent Partial Occlusion of Cortical LTP-Like Plasticity in Major Depression
10.1038/npp.2015.310 · 2016
Microglial-driven changes in synaptic plasticity: A possible role in major depressive disorder
10.1016/j.psyneuen.2018.12.233 · 2019
Intermittent theta-burst stimulation improves motor function by inhibiting neuronal pyroptosis and regulating microglial polarization via TLR4/NF-κB/NLRP3 signaling pathway in cerebral ischemic mice
10.1186/s12974-022-02501-2 · 2022
Advancing an inflammatory subtype of major depression
10.1176/appi.ajp.20250289 · 2025
HMGB1/STAT3/p65 axis drives microglial activation and autophagy in chronic stress-induced major depressive disorder
10.1016/j.jare.2023.06.003 · 2023
Extracellular HMGB1 as a therapeutic target in inflammatory diseases
10.1080/14728222.2018.1439924 · 2018
HMGB1 induces an inflammatory response in the chorioamniotic membranes that is partially mediated by the inflammasome
10.1095/biolreprod.116.144139 · 2016
Minocycline prevents depressive-like behavior through inhibiting the release of HMGB1 from microglia and neurons
10.1016/j.bbi.2020.06.019 · 2020
High-mobility group box 1 (HMGB1) crosses the BBB bidirectionally
10.1016/j.bbi.2023.04.018 · 2023
Role of high mobility group box protein 1 in depression: a mechanistic and therapeutic perspective
10.5498/wjp.v12.i6.779 · 2022
HMGB1 in nervous system diseases: a common biomarker and potential therapeutic target
10.3389/fneur.2022.1029891 · 2022
Ventral striatal islands of Calleja neurons bidirectionally mediate depression-like behaviors in mice
10.1038/s41467-023-42662-z · 2023
Physical exercise mediates cortical synaptic protein lactylation to improve stress resilience
10.1016/j.cmet.2024.07.018 · 2024
BGP-15 alleviates LPS-induced depression-like behavior by promoting mitophagy
10.1016/j.bbi.2024.04.036 · 2024
A chronic unpredictable stress protocol to model anhedonic and resilient behaviors in C57BL/6J mice
10.1016/j.xpro.2022.101659 · 2022
Sucrose preference test for measurement of stress-induced anhedonia in mice
10.1038/s41596-018-0011-z · 2018
Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice
10.3791/52434-v · 2015
The tail suspension test: a new method for screening antidepressants in mice
10.1007/bf00428203 · 1985
Behavioral despair in mice: a primary screening test for antidepressants
1977
Glycyrrhizic acid ameliorates the kynurenine pathway in association with its antidepressant effect
10.1016/j.bbr.2018.01.024 · 2018
Minocycline prevents depressive-like behavior through inhibiting the release of HMGB1 from microglia and neurons
10.1016/j.bbi.2020.06.019 · 2020
Glycyrrhizic acid treatment ameliorates anxiety-like behaviour via GLT1 and Per1/2-dependent pathways
10.1016/j.jep.2024.118013 · 2024
Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial
10.1016/s0140-6736(18)30295-2 · 2018
Unresolved referenced work
2019
Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression
10.1038/s41398-022-02297-y · 2023
High-mobility group box 1 protein: friend and foe
10.1016/j.cytogfr.2006.01.003 · 2006
HMGB1 in development and diseases of the central nervous system
10.1007/s12035-012-8264-y · 2012
Ds-HMGB1 and fr-HMGB1 induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1
10.1016/j.bbi.2016.09.017 · 2017
High-mobility group box 1-mediated microglial activation induces anxiodepressive-like behaviors in mice with neuropathic pain
10.1016/j.pnpbp.2019.02.005 · 2019
Toll-like receptors in defense and damage of the central nervous system
10.1007/s11481-007-9071-5 · 2007
Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats
10.1096/fj.07-8770com · 2007
Anti-high mobility group box-1 antibody therapy for traumatic brain injury
10.1002/ana.23602 · 2012
The Effect and Regulatory Mechanism of High Mobility Group Box-1 Protein on Immune Cells in Inflammatory Diseases
10.3390/cells10051044 · 2021
Therapeutic effects of anti-HMGB1 monoclonal antibody on pilocarpine-induced status epilepticus in mice
10.1038/s41598-017-01325-y · 2017
Selective activation of ABCA1/ApoA1 signaling in the V1 by magnetoelectric stimulation ameliorates depression via regulation of synaptic plasticity
10.1016/j.isci.2022.104201 · doi-reference
Intermittent theta burst stimulation ameliorates cognitive deficit and attenuates neuroinflammation via PI3K/Akt/mTOR signaling pathway in Alzheimer's-like disease model
10.3389/fnagi.2022.889983 · doi-reference
The blood-brain barrier permeability of 18β-glycyrrhetinic acid
10.1007/s10571-012-9839-x · doi-reference
Administration-route dependency of absorption of glycyrrhizin in rats
10.1248/bpb.18.337 · doi-reference
Glycyrrhizic acid as an adjunctive treatment for depression through antiinflammation: a randomized placebo-controlled clinical trial
10.1016/j.jad.2020.01.048 · doi-reference
High mobility group box 1 (HMGB1) inhibition attenuates lipopolysaccharide-induced cognitive dysfunction and sickness-like behavior in mice
10.1007/s12026-022-09295-8 · doi-reference
HMGB1 mediates depressive behavior induced by chronic stress through activating the kynurenine pathway
10.1016/j.bbi.2017.11.017 · doi-reference